Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B cell impairment and increases the risk for infections - a retrospective matched cohort study.

[img]
Preview
PDF (Publisher's version) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
626kB
[img]
Preview
PDF (Supplementary Appendix) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB

Item Type:Letter
Title:Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B cell impairment and increases the risk for infections - a retrospective matched cohort study.
Creators Name:Launspach, M. and Temel, D. and Ohlendorf, E. and Zirngibl, F. and Materne, B. and Oevermann, L. and Deubzer, H.E. and Henssen, A.G. and Künkele, A. and Hundsdörfer, P. and von Bernuth, H. and Pruß, A. and Eggert, A. and von Stackelberg, A. and Lang, P. and Schulte, J.H.
Keywords:Autologous Transplantation, Cohort Studies, Hematopoietic Stem Cell Transplantation, Retrospective Studies, Risk Factors, Rituximab
Source:Haematologica
ISSN:0390-6078
Publisher:Ferrata Storti Foundation
Volume:108
Number:1
Page Range:267-272
Date:January 2023
Official Publication:https://doi.org/10.3324/haematol.2022.281134
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library